Dr. Michael James Choi, MD

Dr. Choi practices at Capitol SC in Washington, District of Columbia.

Dr. Choi's NPI, 1487606372, was assigned on May 17, 2006. Dr. Choi graduated from The Johns Hopkins University School of Medicine in 1987. Dr. Choi holds Maryland license D46375.

Dr. Choi's primary practice is Capitol SC, at 2021 K Nw St, Washington, DC 20006 in District Of Columbia County. The practice phone is (202) 423-7825.

Dr. Choi's primary practice is Capitol SC in Washington, District of Columbia. Dr. Choi is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Choi to 1 more hospital, 2 dialysis centers and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choi practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Choi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Choi is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Choi's licenses on file in 3 states: Maryland, District of Columbia and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Choi treats.

CMS data shows 885 Medicare services from Dr. Choi across 5 procedure codes in 2024, for 254 Medicare patients. Medicare paid $90,570 for them.

CMS counts 254 Medicare patients who saw Dr. Choi in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 5.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Choi's median patient age at 61, with 44% women.

In 2024, Dr. Choi wrote 267 Medicare Part D claims for 37 patients. 95% of them were for generic drugs. CMS names the drug for 115 of them, across 7 drugs with 11 or more claims each, at $3,119 in total drug cost. In 2023, CMS named 100 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Choi for performance year 2024, reported as part of a group. Dr. Choi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Choi as offering telehealth.

Dmand AI links 43 papers to Dr. Choi, published from 2008 to 2023. 2015 was the busiest year, with 6. The most frequent topics are Renal Insufficiency, Chronic, Nephrology and Kidney Failure, Chronic. Dr. Choi has published most often in Clin J Am Soc Nephrol. Dr. Choi's most frequent co-authors are Bernard Georges Jaar, MD, Michelle Mae Estrella, MD and Mohamed G. Atta, MD.

Dmand AI links Dr. Choi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Macular dystrophy, corneal type 1 and Nephrosis, Lipoid.

CMS Open Payments shows 23 general payments to Dr. Choi from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. GlaxoSmithKline, LLC. paid the most, $4,165.

Dmand AI lists 3 awards for Dr. Choi, most recently Super Doc in 2014.

Dr. Choi graduated from The Johns Hopkins University School of Medicine in 1987.

Dr. Choi is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.